4//SEC Filing
KARSEN PERRY A 4
Accession 0000899243-21-027012
CIK 0001815776other
Filed
Jun 30, 8:00 PM ET
Accepted
Jul 1, 7:00 PM ET
Size
15.4 KB
Accession
0000899243-21-027012
Insider Transaction Report
Form 4
KARSEN PERRY A
Director
Transactions
- Award
Stock Option (right to buy)
2021-03-17+18,698→ 18,698 totalExercise: $6.11Exp: 2031-03-16→ Common Stock (18,698 underlying) - Award
Stock Option (right to buy)
2021-01-13+74,794→ 74,794 totalExercise: $0.30Exp: 2031-01-12→ Common Stock (74,794 underlying) - Award
Series B Preferred Stock
2021-03-11$5.06/sh+19,763$100,001→ 19,763 total→ Common Stock (8,126 underlying) - Conversion
Series B Preferred Stock
2021-06-29−19,763→ 0 total→ Common Stock (8,126 underlying) - Conversion
Common Stock
2021-06-29+8,126→ 164,034 total
Footnotes (5)
- [F1]These shares of Series B Preferred Stock were convertible at any time at the holder's election and automatically converted on a 2.432-for-one basis into shares of the Issuer's common stock immediately upon the closing of the Issuer's initial public offering ("IPO") without payment of additional consideration. The Series B Preferred Stock had no expiration date.
- [F2]On June 21, 2021, the Issuer completed a one-for-2.432 reverse stock split of the Issuer's Common Stock ("Reverse Stock Split"). This amount has been adjusted to give effect to this Reverse Stock Split.
- [F3]This transaction occurred prior to the IPO and is being reported on Form 4 solely for purposes of compliance with Rule 16a-2(a) under the Securities Exchange Act of 1934, as amended. The securities covered by such transaction were previously included on the Reporting Person's Form 3.
- [F4]1/48th of the shares subject to such option vest and become exercisable in substantially equal monthly installments on each monthly anniversary of June 5, 2020, subject to the Reporting Person's continuous service to the Issuer on each such date. The option provides for an early exercise provision of unvested shares, subject to the Issuer's right to repurchase.
- [F5]1/48th of the shares subject to such option vest and become exercisable in substantially equal monthly installments on each monthly anniversary of March 17, 2021, subject to the Reporting Person's continuous service to the Issuer on each such date.
Documents
Issuer
Graphite Bio, Inc.
CIK 0001815776
Entity typeother
Related Parties
1- filerCIK 0001260573
Filing Metadata
- Form type
- 4
- Filed
- Jun 30, 8:00 PM ET
- Accepted
- Jul 1, 7:00 PM ET
- Size
- 15.4 KB